— Know what they know.
Not Investment Advice

FERMENTA.BO BSE

Fermenta Biotech Ltd.
1W: +14.5% 1M: +14.1% 3M: +59.5% YTD: +77.7% 1Y: +53.3% 3Y: +261.3% 5Y: +82.5%
₹558.15 ($5.80)
+6.80 (+1.23%)
 
BSE · Healthcare · Biotechnology · Tech Score Strong Buy · Power 72 · ₹15.7B mcap · 8M float · 0.303% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap₹15.7B ($162.9M)
52W Range256.4-579.65
Volume13,006
Avg Volume23,487
Beta-0.23
Dividend₹3.75
Analyst Ratings
No analyst coverage
Company Info
CEOPrashant Prabhakar Nagre
Employees558
SectorHealthcare
IndustryBiotechnology
IPO Date2024-12-30
DIL Complex
Thane, MH 400610
IN
+91 22 6798 0888 |
About Fermenta Biotech Ltd.

Fermenta Biotech Ltd. primarily focuses on the creation and provision of Vitamin D3. Their extensive range of offerings includes various forms like crystalline, oil, resin in oil, cold water dispersible (CWD) preparations, and feed-grade powder. These adaptable products are utilized across multiple sectors, such as in pharmaceutical injectables, soft gel capsules, premixes, and for enhancing the nutritional value of food and beverages. The company's business activities are structured into two main divisions: the Chemicals/Bulk Drug segment, which involves the production and sale of chemicals, pharmaceutical ingredients, and enzymes; and the Property segment, dedicated to leasing out real estate. Established on May 1, 1951, by Vijay Kumar Raju Datla, the firm maintains its headquarters in Mumbai, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms